“Cutaneous Manifestations of IBD: Potential Role of Vedolizumab” (2024) Canadian Dermatology Today, 5(1), pp. 19–27. Available at: https://canadiandermatologytoday.com/article/view/5-1-Lipson (Accessed: 17 September 2026).